-
Forward Look
Predicting Colorectal Cancer RecurrenceLiquid biopsy tests can find tiny amounts of disease that remain after surgery and chemotherapy.
by Kris Conner
-
Forward Look
New Treatment Approved for Lung CancerKRAS mutations were once thought to be resistant to drug therapy.
by Carisa Brewster
-
Healthy Habits
An Alternative to MeatAre new plant-based meat alternatives a better way to satisfy burger cravings?
by Erin O’Donnell
-
Forward Look
Spotlight on Small Cell Lung CancerTreatments for small cell lung cancer have remained virtually the same for decades. Now, experts say that hope is on the horizon.
by Isobel Whitcomb
-
Facts and Stats
Looking Closely at Lung CancerWhile there are many kinds of lung cancer, screening recommendations are standard across the board.
by Bradley Jones
-
Forward Look
What’s Next? Fall 2021Oncolytic viruses to treat pediatric glioma.
by Natalie Slivinski
-
Forward Look
Putting Data to WorkResearchers create breast cancer prediction models tailored for Asian Americans.
by Bradley Jones
-
An Emerging Treatment for Metastatic Prostate CancerA drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
Drug Delays Recurrence in People With Early-Stage Breast CancerPeople who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
-
Moving Away From the Maximum Tolerated DoseThe FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
